Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis
Caocci G.
First
;Mulas O.Second
;Annunziata M.;Efficace F.;Cattaneo D.;Specchia G.;La Nasa G.;
2018-01-01
File | Size | Format | |
---|---|---|---|
articolo 1.pdf Solo gestori archivio
Type: versione editoriale
Size 1.18 MB
Format Adobe PDF
|
1.18 MB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.